Standard BioTools
LAB
$2.57
Share price
2.80%
Change (1 day)
12.23%
Change (1 year)
Standard BioTools (LAB) - Cash on Hand
Cash on Hand as of December 2023 : $0.11 B
According to Standard BioTools's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Standard BioTools - Cash on Hand chart (from 2007 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -30.7% |
| 2022-12-31 | $0.16 B | 482.7% |
| 2021-12-31 | $28.45 M | -58.48% |
| 2020-12-31 | $68.52 M | 16.85% |
| 2019-12-31 | $58.63 M | -38.53% |
| 2018-12-31 | $95.4 M | 51.1% |
| 2017-12-31 | $63.13 M | 6.24% |
| 2016-12-31 | $59.43 M | -37.42% |
| 2015-12-31 | $94.97 M | -17.63% |
| 2014-12-31 | $0.11 B | 36.7% |
| 2013-12-31 | $84.34 M | 5.42% |
| 2012-12-31 | $80.01 M | 49.65% |
| 2011-12-31 | $53.46 M | 834.25% |
| 2010-12-31 | $5.72 M | -60.81% |
| 2009-12-31 | $14.6 M | -17.95% |
| 2008-12-31 | $17.79 M | -55.91% |
| 2007-12-31 | $40.36 M | 58.17% |
| 2006-12-31 | $25.51 M |